Le latest from Wuhan they shiver, but there is also good news. In 2003 it took 20 months to find the first experimental treatment against the newly identified virus: in 2020 it will take 3 months for the first treatments against Wuhan's Coronavirus.
China has already published the genome sequence of the Wuhan Coronavirus and experimental vaccines are expected to be tested in humans by April 2020 for a coronavirus vaccine in record time.
In other words, within the next 90 days, a number of potential experimental vaccines will already be available for use against the new coronavirus that is spreading in China and beyond.
It is the fastest timeline in which the NIH agency's National Institute of Allergy and Infectious Diseases has ever developed for a vaccine against a new disease.
Chinese scientists have identified the genetic sequence of the novel coronavirus with astonishing speed, and officials have made it public within days. On January 24, 2020, the US CDC published the entire genome of the 2019-nCoV virus detected in the first US patient in Seattle, Washington on GenBank.
CDC developed a real-time reverse polymerase chain reaction test (rRT-PCR). It is able to diagnose 2019-nCoV in respiratory and serum samples from clinical samples.
Coronavirus, in 2003 it took much longer for a vaccine
In the 2003 outbreak of severe acute respiratory syndrome (SARS), it took US scientists a whopping 20 months to transition from the genetic sequence to the first phase of human trials.
The 2019-nCoV infection caused clusters of severe respiratory diseases, with admission to intensive care and high mortality.
Rapid treatment and mRNA
US biotech company Moderna Inc specializes in ribonucleic acid (RNA) -based vaccines. A chemical messenger that contains instructions for making proteins. Moderna is collaborating with the NIH to develop the new coronavirus (2019-nCoV) vaccine.
The aces in the sleeve of Moderna? A remarkable technological platform. Moderna has created an mRNA technology platform that works much like an operating system on a computer. It is designed in such a way that it can be linked and played interchangeably with different programs. In our case, the "program" or "app" is our drug mRNA - the unique sequence of mRNA that codes for a protein.
In practice, the system can make several "attempts" on a vaccine, it can do it in a short time and motivate everything.
If you combine the fully integrated production site and development experience, you understand how these skills are fundamental.
Skills that allowed Moderna to quickly identify and progress a vaccine candidate.
